Company page

Vaxxinity, Inc.

Vaxxinity, Inc. is a public company traded under the ticker VAXX in the American market, with a market capitalization of approximately $14,066 million. The company focuses on developing innovative vaccines and therapies to address various health challenges. Vaxxinity aims to improve public health through its research and development efforts in the biotechnology sector.